Literature DB >> 648154

Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.

D E Moore, S Roy, F Z Stanczyk, D R Mishell.   

Abstract

Entities:  

Keywords:  Biology; Bleeding; Clinical Research; Contraception; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin--analysis; Contraceptive Agents--analysis; Contraceptive Implants--administraction and dosage; Contraceptive Implants--side effects; Contraceptive Methods--administraction and dosage; Contraceptive Methods--side effects; Diseases; Endocrine System; Estradiol--analysis; Estrogens; Family Planning; Hormones; Levonorgestrel--analysis; Menorrhagia; Menstruation Disorders; Metrorrhagia; Ovulation; Physiology; Progestational Hormones; Progesterone--analysis; Reproduction; Research Methodology; Signs And Symptoms

Mesh:

Substances:

Year:  1978        PMID: 648154     DOI: 10.1016/0010-7824(78)90078-1

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  5 in total

1.  Facts about an implantable contraceptive: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  [Concerning an implantable contraceptive: a memorandum of a WHO meeting].

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 3.  Controlled-release delivery systems for hormones. A review of their properties and current therapeutic use.

Authors:  L R Beck; V Z Pope
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 4.  Levonorgestrel. Clinical pharmacokinetics.

Authors:  K Fotherby
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

5.  Formulation and performance characterization of radio-sterilized "progestin-only" microparticles intended for contraception.

Authors:  Shivanand Puthli; Pradeep Vavia
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.